Certified by Founder Lodge
Cross-Border Impact Ventures
Canada - Toronto, Ontario
INVESTOR
1 Disclosed Funding Rounds $11,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cross Border Impact Ventures aims to be the preferred investor for transformative health technology companies with the potential of meeting the needs of women, children and adolescents across
| Company | Date | Round | Raised |
|---|---|---|---|
 Daye |
October, 26 ,2022 | Series A | $11,500,000 |
 OncoLens |
July, 17 ,2023 | Unknown | |
 Raydiant Oximetry, Inc. |
June, 05 ,2024 | Series A | $7,500,000 |
 Oxford Cancer Analytics |
January, 10 ,2025 | Series A | $11,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
